Delivery Order SPE2DB24D1007-SPE2DB25FCBKL
Award Date
4/22/25
Potential Completion Date
4/23/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $2,147.76 firm fixed-price contract is for the delivery of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of January 16, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,430.38, is for the delivery of fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of February 14, 2025 and is a firm fixed-price type. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,150.36 firm fixed-price contract is for the delivery of fexofenadine hydrochloride 180 mg tablets. The contract has an ultimate completion date of March 5, 2025 and is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fexofenadine HCL 180 mg tablets. The $1,813.85 firm-fixed-price contract has a completion date of September 26, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000, respectively, to provide a wide range of pharmaceutical and medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,337.28, is for the delivery of 4,567,094,436 units of the drug Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation or subcontractors....
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The $1,640.52 firm fixed price contract is for the delivery of 4,558,478,347 units of Fexofenadine HCL 180 mg tablets. This order is made under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and will...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,317.89 firm fixed-price contract is for the delivery of 4,567,489,334 tablets of Fexofenadine HCL 180 mg, a prescription antihistamine medication, with a performance period running through March 2025. The contract has no set-aside designation, indicating it was competitively awarded. Amerisourcebergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Fexofenadine HCL 180 mg tablets. The contract is a Delivery Order with a Firm Fixed Price type, valued at $1,422.24, and has a period of performance through February 21, 2024. The contract was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.44, is for the delivery of Fexofenadine HCL 180 mg Tablets. This is a firm fixed-price delivery order contract with a completion date of May 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,390.41, is for the procurement of fexofenadine hydrochloride 180 mg tablets, a prescription medication. The contract has an ultimate completion date of July 11, 2024 and is a firm fixed-price delivery order. The award is not associated with a set-aside designation, indicating open competition....